X
Group 4 Created with Sketch.
Your changes have been saved
Episode 39 of 40

Improving Patient Understanding of the Language of Precision Medicine

Duration: 32:07
Genomic or biomarker testing? Germline or genetic testing? The various terms that providers use about testing can cause confusion and lead to suboptimal testing and care.Nikki Martin, MA, Director of Precision Medicine Initiatives at LUNGevity Foundation, talks about the work of the Consistent Testi
Snippets are a new way to share audio!
You can clip a small part of any file to share, add to playlist, and transcribe automatically. Just click the to create your snippet!
Snippets: Clips of Improving Patient Understanding of the Language of Precision Medicine that people like
There are currently no snippets from Improving Patient Understanding of the Language of Precision Medicine.
Snippets are an easy way to highlight your favorite soundbite from any piece of audio and share with friends, or make a trailer for ‎The JADPRO Podcast
Playlists that Improving Patient Understanding of the Language of Precision Medicine appears on.
There are currently no playlists containing this audio.
Add this audio track to one of your playlists
Add to Playlist
Up Next
Full Description
Back to Top
Genomic or biomarker testing? Germline or genetic testing? The various terms that providers use about testing can cause confusion and lead to suboptimal testing and care.Nikki Martin, MA, Director of Precision Medicine Initiatives at LUNGevity Foundation, talks about the work of the Consistent Testing Terminology Working Group to encourage the use of consistent, plain language terms for biomarker and genetic testing that are applicable across cancer types. Allyson Price, MPAS, PA-C, a member of the working group, describes the important role of the advanced practitioner in explaining testing results to patients. The official recommendations are: “Biomarker testing” is the preferred term for tests that identify characteristics, targetable findings, or other test results originating from malignant tissue. “Genetic testing for an inherited mutation” or “genetic testing for inherited cancer risk” are recommended to describe tests to identify germline mutation. Resources: Working Group White PaperASCO abstractCancer.Net article
Up Next
Add to playlist
New playlist

Embed

COPY
Embed Options
Create Playlist
Select the Station you want to upload this audio to
Station
0 / 140
0 / 2000
Playlist Icon Image:
(.jpg, .png, min size 500x500px)
Privacy
Subscribers
Your
voice
matters.
Discover & Listen to the world’s largest free collection of audio
Password reset

Enter your email address that you used to register. We'll send you an email with your username and a link to reset your password.



If you still need help, contact Vurbl Support
Password reset sent

You have been sent instructions on resetting you password to the email associated with your account. Please check your email and signing in again.


Back to Sign In
If you still need help, contact Vurbl Support
Your
voice
matters.
Discover & Listen to the world’s largest free collection of audio
Reset password

Please enter your new password below.



If you still need help, contact Vurbl Support
Your voice matters.
Discover & Listen to the world’s largest free collection of audio
Verify Email

Enter your email address that you used to register. We'll send you an email with a link to verify your email.



Cancel
Delete Profile
Are you sure? We will miss you :'(
Delete
Delete Audio
Are you sure?
Delete
Delete Playlist
Are you sure you want to delete this playlist?
Delete
Notifications Mark all as read
    You currently have no notifications
    Edit Snippet
    0 / 140
    0 / 140